查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1413916

Dydrogesterone市場：按類型、應用分類 - 2024-2030 年全球預測

Dydrogesterone Market by Type (Dydrogesterone D5, Dydrogesterone D6), Application (Gynecological Diseases, Infertility) - Global Forecast 2024-2030
出版日期: | 出版商: 360iResearch | 英文 199 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

預計2023年Dydrogesterone市場規模為5.6786億美元，2024年將達6.1812億美元，2030年將達10.69億美元，複合年成長率為9.45%。

Dydrogesterone的全球市場

主要市場統計
基準年[2023] 56786萬美元
預測年份 [2024] 61812萬美元
預測年份 [2030] 10.69億美元
複合年成長率（%） 9.45%
地屈孕酮市場-IMG1

Dydrogesterone是一種合成激素，其化學結構和藥理作用與內源性黃體酮相似。它被歸類為孕激素，是一種用來模仿天然激素孕酮作用的藥物。Dydrogesterone具有很強的黃體素作用，因此非常適合黃體素缺乏症。它經常用於各種臨床環境，包括月經失調、黃體功能障礙引起的不孕症以及更年期症狀的荷爾蒙替代療法 (HRT)。與其他合成黃體素藥物不同，Dydrogesterone在治療劑量下不會抑制排卵，因此當需要維持排卵週期時，它是首選。由於女性人口老化的增加、生殖健康問題的普遍存在、醫療基礎設施的改善、醫療的進步以及政府對婦女健康的支持政策，Dydrogesterone市場正在見證成長。儘管成長前景良好，但嚴格的藥品核准法規、副作用和市場競爭等挑戰正在阻礙市場擴張。然而，開拓新的藥物輸送機制、引入具有成本效益的學名藥以及針對廣泛治療應用的聯合治療的研究為未來的市場成長提供了利潤豐厚的機會。

區域洞察

美洲地Dydrogesterone市場正在經歷穩定的成長模式。人們對婦女健康問題的認知不斷提高，以及子宮內膜異位症和月經等疾病在女性族群中的流行，正在推動對荷爾蒙相關治療方案的需求。由於其完善的醫療保健基礎設施、大型製藥公司的存在以及支持性的法律規範，美國對該地區的市場成長做出了重大貢獻。除此之外，此類藥物的高購買力和保險覆蓋範圍正在支持Dydrogesterone市場的強勁發展。由於荷爾蒙替代療法的廣泛接受和有利的醫療報銷政策，歐洲是歐洲、中東和非洲地Dydrogesterone市場的主要貢獻者。該地區成熟的醫療保健體係有助於其強大的市場地位。另一方面，中東和非洲地區由於醫療投資的增加和婦女生殖健康普及的逐漸普及，儘管其成長率低於歐洲，但仍顯示出成長潛力。亞太地Dydrogesterone市場預計將出現最高成長率。推動這種擴張的因素包括婦科疾病發病率上升、勞動力中女性人數的增加、醫療基礎設施的改善以及對婦女健康問題的認知提高。尤其是中國和印度等國家的醫藥產業正在快速成長，這些國家由於人口眾多且醫療旅遊不斷增加而成為巨大的市場。

FPNV定位矩陣

FPNV定位矩陣對於評估地Dydrogesterone市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標，以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估，供應商被分為四個成功程度不同的像限。最前線 (F)、探路者 (P)、利基 (N) 和重要 (V)。

市場佔有率分析

市場佔有率分析是一種綜合工具，可以對Dydrogesterone市場供應商的現狀進行深入而詳細的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻，以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外，該分析還提供了對該行業競爭特徵的寶貴考察，包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。這種詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略，從而在市場上獲得競爭優勢。

該報告對以下幾個方面提供了寶貴的見解：

1-市場滲透率：提供有關主要企業所服務的市場的全面資訊。

2-市場開拓：我們深入研究利潤豐厚的新興市場，並分析它們在成熟細分市場中的滲透率。

3- 市場多元化：提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。

4-競爭力評估與資訊：對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行全面評估。

5- 產品開發與創新：提供對未來技術、研發活動和突破性產品開發的見解。

本報告解決了以下關鍵問題：

1-Dydrogesterone市場的市場規模和預測是多少？

2-在Dydrogesterone市場預測期內需要考慮投資的產品、細分市場、應用和領域有哪些？

3-地Dydrogesterone市場的技術趨勢和法律規範是什麼？

4-Dydrogesterone市場主要供應商的市場佔有率是多少？

進入5-Dydrogesterone市場合適的型態和策略手段是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 老年女性人口的增加和生殖健康問題的蔓延
      • 政府對婦女健康的支持政策
      • 改善整個經濟領域的衛生基礎設施
    • 抑制因素
      • 與Dydrogesterone生產相關的高成本
    • 機會
      • 地Dydrogesterone學名藥核准增加
      • 市場相關人員加大投資和擴張
    • 任務
      • 與Dydrogesterone藥物相關的嚴格監管核准流程
  • 市場區隔分析
    • 類型：DydrogesteroneD6在高精度分析和臨床檢測的優勢
    • 用途：Dydrogesterone在婦科疾病症狀緩解和荷爾蒙調節的重要用途
  • 市場趨勢分析
  • 高通膨的累積效應
  • 波特五力分析
  • 價值鍊和關鍵路徑分析
  • 法律規範

第6章Dydrogesterone市場：依類型

  • 介紹
  • D5
  • D6

第7章Dydrogesterone市場：依應用分類

  • 介紹
  • 婦科疾病
  • 不孕症

第8章美洲地Dydrogesterone市場

  • 介紹
  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第9章亞太地區Dydrogesterone市場

  • 介紹
  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第10章歐洲、中東和非洲地Dydrogesterone市場

  • 介紹
  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第11章競爭形勢

  • FPNV定位矩陣
  • 市場佔有率分析：主要企業
  • 主要企業競爭情境分析
    • 併購
    • 獎項/獎勵/擴展

第12章競爭產品組合

  • 主要公司簡介
    • Abbott Laboratories
    • Adalvo Limited
    • Alembic Pharmaceuticals Limited
    • Axios Research
    • Clearsynth
    • Dr. D Pharma
    • Gufic Group
    • H & Care Incorp
    • Jagsonpal Pharmaceuticals Ltd.
    • Mankind Pharma Limited
    • Medley Pharmaceuticals Ltd.
    • Merck KGaA
    • Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
    • Santa Cruz Biotechnology, Inc.
    • Simson Pharma Limited
    • Solitaire Pharmacia Private Limited
    • Somacare
    • Synokem Pharmaceuticals Ltd.
    • Taj Pharmaceuticals Limited
    • Theramex
    • TLC Pharmaceutical Standards Ltd.
    • Viatris Inc.
    • VIVAN Life Sciences
    • Zuventus Healthcare Limited
  • 主要產品系列

第13章附錄

  • 討論指南
  • 關於許可證和定價
Product Code: MRR-144C638C9217

[199 Pages Report] The Dydrogesterone Market size was estimated at USD 567.86 million in 2023 and expected to reach USD 618.12 million in 2024, at a CAGR 9.45% to reach USD 1,069.00 million by 2030.

Global Dydrogesterone Market

KEY MARKET STATISTICS
Base Year [2023] USD 567.86 million
Estimated Year [2024] USD 618.12 million
Forecast Year [2030] USD 1,069.00 million
CAGR (%) 9.45%
Dydrogesterone Market - IMG1

Dydrogesterone is a synthetic hormone similar in chemical structure and pharmacological effect to endogenous progesterone. It is classified as a progestin, which is a type of medication used to replicate the effects of the natural hormone progesterone. Dydrogesterone possesses a strong progestational effect, which makes it highly suitable for conditions related to progesterone deficiency. It is frequently employed in a variety of clinical situations, such as menstrual disorders, infertility owing to luteal insufficiency, and as part of hormone replacement therapy (HRT) for menopausal symptoms. Unlike some other synthetic progestins, dydrogesterone does not inhibit ovulation at therapeutic doses, making it a preferred option in cases where maintenance of ovulatory cycles is desired. The dydrogesterone market is exhibiting growth with an increasing elderly female population and prevalence of reproductive health issues, improved healthcare infrastructure, medical advancements, and supportive government policies for women's health. Despite the growth prospects, challenges such as stringent drug approval regulations, side effects, and competitive alternatives for dydrogesterone hinder the scope of the market. However, developing novel drug delivery mechanisms, introducing generic versions for cost-effectiveness, and investigating combination therapies for broader therapeutic applications present lucrative opportunities for future market growth.

Regional Insights

The dydrogesterone market in the Americas is experiencing a steady growth pattern. The increase in awareness regarding women's health issues and the prevalence of conditions, including endometriosis and irregular menstrual cycles in the female population, bolster the demand for hormone-related treatment options. The United States is a significant contributor to market growth within this region owing to the well-established healthcare infrastructure, presence of major pharmaceutical companies, and supportive regulatory framework. This is coupled with a higher purchasing power and insurance coverage for such medications, aiding in the positive trajectory of the dydrogesterone market. Europe is a major contributor to the dydrogesterone market in the EMEA, with widespread acceptance of hormone replacement therapies and favorable healthcare reimbursement policies. The region's mature healthcare systems contribute to its strong market position. Meanwhile, the Middle East and Africa regions show potential for growth, albeit at a slower rate compared to Europe, due to increasing healthcare investments and the gradual spread of awareness regarding women's reproductive health. The market for dydrogesterone in the Asia-Pacific region is expected to experience the highest growth rate. Factors fueling this expansion include the rising incidence of gynecological disorders, an increase in the female working population, improving healthcare infrastructure, and growing awareness around women's health issues. Particularly, countries including China and India have burgeoning pharmaceutical sectors and represent considerable markets owing to their large populations and increasing medical tourism.

FPNV Positioning Matrix

The FPNV Positioning Matrix is pivotal in evaluating the Dydrogesterone Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).

Market Share Analysis

The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Dydrogesterone Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.

Key Company Profiles

The report delves into recent significant developments in the Dydrogesterone Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Adalvo Limited, Alembic Pharmaceuticals Limited, Axios Research, Clearsynth, Dr. D Pharma, Gufic Group, H & Care Incorp, Jagsonpal Pharmaceuticals Ltd., Mankind Pharma Limited, Medley Pharmaceuticals Ltd., Merck KGaA, Sandoo Pharmaceuticals and Chemcials Co.,Ltd., Santa Cruz Biotechnology, Inc., Simson Pharma Limited, Solitaire Pharmacia Private Limited, Somacare, Synokem Pharmaceuticals Ltd., Taj Pharmaceuticals Limited, Theramex, TLC Pharmaceutical Standards Ltd., Viatris Inc., VIVAN Life Sciences, and Zuventus Healthcare Limited.

Market Segmentation & Coverage

This research report categorizes the Dydrogesterone Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Type
    • Dydrogesterone D5
    • Dydrogesterone D6
  • Application
    • Gynecological Diseases
    • Infertility
  • Region
    • Americas
      • Argentina
      • Brazil
      • Canada
      • Mexico
      • United States
        • California
        • Florida
        • Illinois
        • New York
        • Ohio
        • Pennsylvania
        • Texas
    • Asia-Pacific
      • Australia
      • China
      • India
      • Indonesia
      • Japan
      • Malaysia
      • Philippines
      • Singapore
      • South Korea
      • Taiwan
      • Thailand
      • Vietnam
    • Europe, Middle East & Africa
      • Denmark
      • Egypt
      • Finland
      • France
      • Germany
      • Israel
      • Italy
      • Netherlands
      • Nigeria
      • Norway
      • Poland
      • Qatar
      • Russia
      • Saudi Arabia
      • South Africa
      • Spain
      • Sweden
      • Switzerland
      • Turkey
      • United Arab Emirates
      • United Kingdom

The report offers valuable insights on the following aspects:

1. Market Penetration: It presents comprehensive information on the market provided by key players.

2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.

3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.

4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.

5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.

The report addresses key questions such as:

1. What is the market size and forecast of the Dydrogesterone Market?

2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Dydrogesterone Market?

3. What are the technology trends and regulatory frameworks in the Dydrogesterone Market?

4. What is the market share of the leading vendors in the Dydrogesterone Market?

5. Which modes and strategic moves are suitable for entering the Dydrogesterone Market?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Limitations
  • 1.7. Assumptions
  • 1.8. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

  • 4.1. Introduction
  • 4.2. Dydrogesterone Market, by Region

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Increasing elderly female population and prevalence of reproductive health issues
      • 5.1.1.2. Supportive government policies for women's health
      • 5.1.1.3. Improved healthcare infrastructure across economies
    • 5.1.2. Restraints
      • 5.1.2.1. High costs associated with dydrogesterone production
    • 5.1.3. Opportunities
      • 5.1.3.1. Rising approval of generic dydrogesterone drugs
      • 5.1.3.2. Growing investment and expansion by market players
    • 5.1.4. Challenges
      • 5.1.4.1. Stringent regulatory approval processes associated with dydrogesterone drugs
  • 5.2. Market Segmentation Analysis
    • 5.2.1. Type: Benefits of dydrogesterone d6 in highly precise analytical and clinical tests
    • 5.2.2. Application: Significant applications of dydrogesterone for symptomatic relief and hormonal regulation in gynecological conditions
  • 5.3. Market Trend Analysis
  • 5.4. Cumulative Impact of High Inflation
  • 5.5. Porter's Five Forces Analysis
    • 5.5.1. Threat of New Entrants
    • 5.5.2. Threat of Substitutes
    • 5.5.3. Bargaining Power of Customers
    • 5.5.4. Bargaining Power of Suppliers
    • 5.5.5. Industry Rivalry
  • 5.6. Value Chain & Critical Path Analysis
  • 5.7. Regulatory Framework

6. Dydrogesterone Market, by Type

  • 6.1. Introduction
  • 6.2. Dydrogesterone D5
  • 6.3. Dydrogesterone D6

7. Dydrogesterone Market, by Application

  • 7.1. Introduction
  • 7.2. Gynecological Diseases
  • 7.3. Infertility

8. Americas Dydrogesterone Market

  • 8.1. Introduction
  • 8.2. Argentina
  • 8.3. Brazil
  • 8.4. Canada
  • 8.5. Mexico
  • 8.6. United States

9. Asia-Pacific Dydrogesterone Market

  • 9.1. Introduction
  • 9.2. Australia
  • 9.3. China
  • 9.4. India
  • 9.5. Indonesia
  • 9.6. Japan
  • 9.7. Malaysia
  • 9.8. Philippines
  • 9.9. Singapore
  • 9.10. South Korea
  • 9.11. Taiwan
  • 9.12. Thailand
  • 9.13. Vietnam

10. Europe, Middle East & Africa Dydrogesterone Market

  • 10.1. Introduction
  • 10.2. Denmark
  • 10.3. Egypt
  • 10.4. Finland
  • 10.5. France
  • 10.6. Germany
  • 10.7. Israel
  • 10.8. Italy
  • 10.9. Netherlands
  • 10.10. Nigeria
  • 10.11. Norway
  • 10.12. Poland
  • 10.13. Qatar
  • 10.14. Russia
  • 10.15. Saudi Arabia
  • 10.16. South Africa
  • 10.17. Spain
  • 10.18. Sweden
  • 10.19. Switzerland
  • 10.20. Turkey
  • 10.21. United Arab Emirates
  • 10.22. United Kingdom

11. Competitive Landscape

  • 11.1. FPNV Positioning Matrix
  • 11.2. Market Share Analysis, By Key Player
  • 11.3. Competitive Scenario Analysis, By Key Player
    • 11.3.1. Merger & Acquisition
      • 11.3.1.1. Theramex Announces Agreement to Acquire the European Rights to Duphaston and Femoston From Viatris, Inc.
    • 11.3.2. Award, Recognition, & Expansion
      • 11.3.2.1. Aurisco Gets Auxiton (Dydrogesterone) as First Generic Approval in China
      • 11.3.2.2. US Pharma Giant Applies for Nod to Launch Tweaked Version of Drug for Pelvic Pain in Endometriosis

12. Competitive Portfolio

  • 12.1. Key Company Profiles
    • 12.1.1. Abbott Laboratories
    • 12.1.2. Adalvo Limited
    • 12.1.3. Alembic Pharmaceuticals Limited
    • 12.1.4. Axios Research
    • 12.1.5. Clearsynth
    • 12.1.6. Dr. D Pharma
    • 12.1.7. Gufic Group
    • 12.1.8. H & Care Incorp
    • 12.1.9. Jagsonpal Pharmaceuticals Ltd.
    • 12.1.10. Mankind Pharma Limited
    • 12.1.11. Medley Pharmaceuticals Ltd.
    • 12.1.12. Merck KGaA
    • 12.1.13. Sandoo Pharmaceuticals and Chemcials Co.,Ltd.
    • 12.1.14. Santa Cruz Biotechnology, Inc.
    • 12.1.15. Simson Pharma Limited
    • 12.1.16. Solitaire Pharmacia Private Limited
    • 12.1.17. Somacare
    • 12.1.18. Synokem Pharmaceuticals Ltd.
    • 12.1.19. Taj Pharmaceuticals Limited
    • 12.1.20. Theramex
    • 12.1.21. TLC Pharmaceutical Standards Ltd.
    • 12.1.22. Viatris Inc.
    • 12.1.23. VIVAN Life Sciences
    • 12.1.24. Zuventus Healthcare Limited
  • 12.2. Key Product Portfolio

13. Appendix

  • 13.1. Discussion Guide
  • 13.2. License & Pricing

LIST OF FIGURES

  • FIGURE 1. DYDROGESTERONE MARKET RESEARCH PROCESS
  • FIGURE 2. DYDROGESTERONE MARKET SIZE, 2023 VS 2030
  • FIGURE 3. DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2030 (%)
  • FIGURE 5. DYDROGESTERONE MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. DYDROGESTERONE MARKET DYNAMICS
  • FIGURE 7. DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2030 (%)
  • FIGURE 8. DYDROGESTERONE MARKET SIZE, BY TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 9. DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2030 (%)
  • FIGURE 10. DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 12. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 13. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 14. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 15. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 16. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 17. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 18. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 19. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023
  • FIGURE 20. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023

LIST OF TABLES

  • TABLE 1. DYDROGESTERONE MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. DYDROGESTERONE MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL DYDROGESTERONE MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 6. DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D5, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 7. DYDROGESTERONE MARKET SIZE, BY DYDROGESTERONE D6, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 8. DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 9. DYDROGESTERONE MARKET SIZE, BY GYNECOLOGICAL DISEASES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. DYDROGESTERONE MARKET SIZE, BY INFERTILITY, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. AMERICAS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 12. AMERICAS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 13. AMERICAS DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 14. ARGENTINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 15. ARGENTINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 16. BRAZIL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 17. BRAZIL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 18. CANADA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 19. CANADA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 20. MEXICO DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 21. MEXICO DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 22. UNITED STATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 23. UNITED STATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 24. UNITED STATES DYDROGESTERONE MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 25. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 27. ASIA-PACIFIC DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 29. AUSTRALIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 30. CHINA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. CHINA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 32. INDIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 33. INDIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 34. INDONESIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. INDONESIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 36. JAPAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 37. JAPAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 38. MALAYSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. MALAYSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 40. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 41. PHILIPPINES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 42. SINGAPORE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. SINGAPORE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 44. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 45. SOUTH KOREA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 46. TAIWAN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. TAIWAN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 48. THAILAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 49. THAILAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 50. VIETNAM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 51. VIETNAM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 52. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 53. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 54. EUROPE, MIDDLE EAST & AFRICA DYDROGESTERONE MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 55. DENMARK DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 56. DENMARK DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 57. EGYPT DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 58. EGYPT DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 59. FINLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 60. FINLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 61. FRANCE DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 62. FRANCE DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 63. GERMANY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 64. GERMANY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 65. ISRAEL DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 66. ISRAEL DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 67. ITALY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 68. ITALY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 69. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 70. NETHERLANDS DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 71. NIGERIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 72. NIGERIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 73. NORWAY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 74. NORWAY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 75. POLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 76. POLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 77. QATAR DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 78. QATAR DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 79. RUSSIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 80. RUSSIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 81. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 82. SAUDI ARABIA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 83. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 84. SOUTH AFRICA DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 85. SPAIN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 86. SPAIN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 87. SWEDEN DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 88. SWEDEN DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 89. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 90. SWITZERLAND DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 91. TURKEY DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 92. TURKEY DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 93. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 94. UNITED ARAB EMIRATES DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 95. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY TYPE, 2018-2030 (USD MILLION)
  • TABLE 96. UNITED KINGDOM DYDROGESTERONE MARKET SIZE, BY APPLICATION, 2018-2030 (USD MILLION)
  • TABLE 97. DYDROGESTERONE MARKET, FPNV POSITIONING MATRIX, 2023
  • TABLE 98. DYDROGESTERONE MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 99. DYDROGESTERONE MARKET LICENSE & PRICING